Skechers stock soars 10% after earnings crush estimates and company offers upbeat guidance
By Ciara Linnane
Athletic footwear company generates record sales in its latest quarter
Skechers Inc.'s stock soared 10% in after-hours trade Thursday, after the athletic footwear company swept past earnings estimates for the first quarter.
Skechers (SKX) had net income of $206.6 million, or $1.33 a share, for the quarter, up from $160.4 million, or $1.02 a share, in the year-earlier period.
Sales rose 12.5% to a quarterly record of $2.252 billion. The FactSet consensus was for EPS of $1.10 and sales of $2.203 billion.
Gross margin rose 360 basis points to 52.5% from 48.9% a year ago.
"We saw growth of 17% in our direct-to-consumer segment and 10% in wholesale, as well as increases of 15% internationally and 8% domestically," Chief Operating Officer David Weinberg said in prepared remarks.
International sales accounted for 65% of the total, with Europe and EMEA sales up 17%, Asia Pacific up 16% and the Americas up 8%.
For the second quarter, Skechers is expecting sales to range from $2.175 billion to $2.225 billion. It expects EPS of 85 cents to 90 cents.
The FactSet consensus is for EPS of $1.08 on sales of $2.203 billion.
For the full year, the company is expecting sales of $8.725 billion to $8.875 billion and EPS of $$3.95 to $4.10. The FactSet consensus is for EPS of $3.90 and sales of $8.781 billion.
The stock has fallen 5.7% in the year to date, while the S&P 500 SPX has gained 6%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-25-24 2019ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks